LECT2 and metabolic dysfunction-associated steatotic liver disease: The present study shows that circulating LECT2, which has been recently redefined as a hepatokine, is significantly higher in subjects with NAFLD and/or metabolic syndrome compared to those without NAFLD and metabolic syndrome.